The following information is derived from Russian clinical practice, published research, and community protocols: Russian Clinical Protocol (Approved Indication): 0.15% nasal spray solution (Selanc) 250 to 300 mcg per administration (approximately two to three drops per nostril) Three times daily 14-day treatment courses One-month rest period between courses Community Intranasal Protocol: Starting dose: 200 mcg intranasally, two times daily Standard dose: 200 to 400 mcg intranasally, two to three times daily Upper range: Up to 1,000 mcg daily (split across three or more administrations) Subcutaneous Protocol (Less Common): 200 to 500 mcg subcutaneously, once daily Used when nasal spray formulation is unavailable Lyophilized powder reconstituted with bacteriostatic water Cycling Guidelines: Russian clinical practice uses 14-day courses with one-month breaks Community protocols often follow one month on, one month off No evidence of tolerance development within 14-day courses in published data Some users employ continuous low-dose protocols without cycling, though this is not supported by clinical trial data Administration Selank is primarily administered intranasally, which distinguishes it from most peptides in the biohacking space that require subcutaneous injection
Y., White, M
Its designed to help people with autoimmune diseases identify trigger foods , reduce systemic inflammation , and heal gut barrier dysfunction , which is a core contributor to autoimmune disease
Designed to promote skin health and rejuvenation, this cream is formulated with precision, offering targeted therapy to enhance skin repair, elasticity, and overall radiance
